EVIDA Trademark

Trademark Overview


On Monday, October 2, 2023, a trademark application was filed for EVIDA with the United States Patent and Trademark Office. The USPTO has given the EVIDA trademark a serial number of 98207152. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, October 14, 2024. This trademark is owned by Prometheus Laboratories, Inc.. The EVIDA trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases

Medical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics
evida

General Information


Serial Number98207152
Word MarkEVIDA
Filing DateMonday, October 2, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, October 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2024

Trademark Statements


Goods and ServicesMedical services, namely, medical diagnostic, evaluation and screening services; healthcare services, namely, disease management services; medical services, namely, therapeutic drug monitoring and precision-guided dosing services; medical services, namely, providing medical information to health care providers, managed care providers and patients via global computer networks; providing health information in the field of inflammatory and immune-mediated diseases, ulcerative colitis, Crohn's disease, rheumatological diseases, rheumatoid arthritis, psoriatic arthritis, system lupus erythematosus, dermatological diseases, psoriasis, hidradenitis suppurativa, neurological disease, Alzheimer's disease, and migraines; providing medical information relating to medical diagnostic testing; medical consultation; providing a website featuring health care information about services for the diagnosis, prevention, and treatment of inflammatory and immune-mediated diseases
Goods and ServicesMedical research laboratory services featuring testing for medical research purposes; medical research services; providing medical and scientific research information in the field of pharmaceuticals, pharmaceutical discovery and clinical trials to medical and research professionals; providing a website featuring medical research information about medical diagnostics; consulting services in the fields of biotechnology, pharmaceutical discovery, pharmaceutical research and development, medical research laboratory testing, medical diagnostics, proteomics, metabolomics, glycomics, genomics and genetics; pharmaceutical and medical research services; providing medical and scientific research information in the fields of pharmaceuticals, proteomics, metabolomics, glycomics, genomics and genetics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 12, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePrometheus Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Thursday, October 5, 2023NEW APPLICATION ENTERED
Wednesday, May 22, 2024ASSIGNED TO EXAMINER
Monday, August 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 19, 2024NON-FINAL ACTION E-MAILED
Monday, August 19, 2024NON-FINAL ACTION WRITTEN
Monday, August 19, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 19, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 19, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 19, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 19, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, August 19, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 1, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED